Triptorelin Drug Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global triptorelin drug market is anticipated to grow at a CAGR of 4.2% during the forecast period (2022-2028). Prostate Cancer is dominating the highest market share as well as it is one of the most common cancers in American men. North America region holds the largest market share in the global triptorelin drug market owing to rising incidence of prostate cancer and salivary gland cancer and growing prevalence of central precocious puberty among the young patients below the age of eight and nine years. During the projection period, triptorelin pamoate is anticipated to grow at the highest rate. Debiopharm has developed three triptorelin pamoate sustained-release formulations (one, three, and six months).

Triptorelin is a gonadotropin-releasing hormone agonist analogue, it is a peptide injection formulation that was originally developed to treat advanced metastatic prostate cancer. Treatment of uterine fibroids (a benign tumor of muscular tissues in the uterus), endometriosis prior to surgery, early-onset puberty, and female infertility are among the various indications that have emerged since then (in vitro fertilization).

In order to maintain their market position, triptorelin product manufacturers are updating their product portfolios by employing inorganic expansion tactics. For instance, in June 2019, Debiopharm and Ipsen renewed their Decapeptyl agreement, extending and strengthening their strategic cooperation for the development, production, and distribution of Decapeptyl across Europe, as well as some Asian and African regions, until 2034.

Triptorelin drug market growth is being fueled by increased R&D for a variety of therapeutic purposes. The market is growing due to increased research & development in triptorelin for usage in various therapeutic indications by private producers and research institutions. Several clinical trials are now underway to see if triptorelin may be used to treat breast cancer and the Human Immunodeficiency Virus (HIV). Triptorelin’s widespread use in prostate cancer, salivary gland cancer, and central precious puberty is also projected to drive market expansion throughout the forecasted period. Furthermore, triptorelin’s efficacy and safety in the reduction of gonadotropin secretion in prostate cancer and precocious puberty are expanding its market penetration.

Some major players in the market include Arbor Pharmaceuticals, LLC, Debiopharm International SA, Ipsen Pharma, Xbrane Biopharma, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2019, Debiopharm Group and Allergan announced an agreement to begin a transition process for Trelstar (Triptorelin pamoate), with the goal of new licensees taking over Trelstar commercialization in the US and Canada and Allergan’s partnership with Debiopharm being terminated for strategic reasons.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Arbor Pharmaceuticals, LLC, Debiopharm International SA, Ipsen Pharma, Xbrane Biopharma, among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Triptorelin Drug Market Report by Segment

By Type

• Triptorelin Pamoate
• Triptorelin Acetate
• Triptorelin Embonate

By Application

• Prostate Cancer
• Radical Prostatectomy
• Salivary Gland Cancer
• Endometriosis
• Central Precocious Puberty

By Distribution Channel

• Online Pharmacy
• Offline Pharmacy